Flu Vaccine Strains Get Easy OK From FDA Panel, But Desire For More Efficacy Remains
US advisory committee overwhelmingly supports WHO's influenza vaccine strain selections, although data are limited as to why current vaccines are not more effective.
You may also be interested in...
CBER Director Peter Marks said the VRBPAC may need to opine on the immunogenicity data gathered for vaccine updates.
Developing a universal flu vaccine will be iterative process, National Institute of Allergy and Infectious Diseases Anthony Fauci says.
The latest drug development news and highlights from our US FDA Performance Tracker.